ACSRX
Price
$31.29
Change
-$0.13 (-0.41%)
Updated
Sep 5 closing price
Net Assets
12.85B
VIVIX
Price
$71.19
Change
-$0.23 (-0.32%)
Updated
Sep 5 closing price
Net Assets
202.84B
Interact to see
Advertisement

ACSRX vs VIVIX

Header iconACSRX vs VIVIX Comparison
Open Charts ACSRX vs VIVIXBanner chart's image
Invesco Comstock R
Price$31.29
Change-$0.13 (-0.41%)
VolumeN/A
Net Assets12.85B
Vanguard Value Index I
Price$71.19
Change-$0.23 (-0.32%)
VolumeN/A
Net Assets202.84B
ACSRX vs VIVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ACSRX vs. VIVIX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACSRX is a Buy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 203B vs. ACSRX (12.9B). VIVIX pays higher dividends than ACSRX: VIVIX (2.11) vs ACSRX (1.27). ACSRX was incepted earlier than VIVIX: ACSRX (23 years) vs VIVIX (27 years). ACSRX (1.06) is less costly to investors than VIVIX (0.04). ACSRX is a more actively managed with annual turnover of: 26.00 vs. VIVIX (9.00). ACSRX has a lower initial minimum investment than VIVIX: ACSRX (0) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 7.74 vs. ACSRX (4.59). VIVIX return over 5 years is better than : 70.16 vs. ACSRX (58.40).
ACSRXVIVIXACSRX / VIVIX
Total Expense Ratio1.060.042,650%
Annual Report Gross Expense Ratio1.060.042,650%
Fund Existence23 years27 years-
Gain YTD10.0867.866128%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets12.9B203B6%
Annual Yield % from dividends1.272.1160%
Returns for 1 year4.597.7459%
Returns for 3 years16.9636.6146%
Returns for 5 years58.4070.1683%
Returns for 10 years48.63131.6137%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XRTX0.820.01
+1.85%
XORTX Therapeutics
CPT111.361.02
+0.92%
Camden Property Trust
TMCI7.17N/A
N/A
Treace Medical Concepts
AGIO36.01-0.12
-0.33%
Agios Pharmaceuticals
ZENV1.51-0.05
-3.21%
Zenvia